Share on LinkedInShare on LinkedIn

ARTICLE · 03 OCTOBER 2016

Inherent Written Description

It has been well established that 35 U.S.C. § 112 contains both a written description requirement and an enablement requirement Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co., 598 F.3d 1336, 1341.

United StatesIntellectual Property

It has been well established that 35 U.S.C. § 112 contains both a written description requirement and an enablement requirement Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co., 598 F.3d 1336, 1341 (Fed. Cir. 2010) (en banc.). It has been further established that the standard for enablement as applied to meeting the requirements for 35 U.S.C. § 112 is different from the standard for enablement to determine if a disclosure is sufficiently enabled to anticipate a reference.  Rasmusson v. Smithkline Beecham Corp., Case Nos. 04-1192, -1192 (Fed. Cir. June 27, 2005). Because of the different standards applied a disclosure in a prior art reference may be sufficiently enabling to anticipate a reference, but the same exact disclosure would not be sufficient to support a claim in a patent. Is the court now moving to a similar bifurcation of standards for written description?

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from